ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2018

Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's disease.

Dan P Covey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.